| 1 |
26486415 | Elucidating the use of enoxaparin in non-ST-elevation acute coronary syndromes (NSTE-ACS). | 2016 Feb |
1 |
| 2 |
19517216 | Efficacy of enoxaparin, certoparin and dalteparin in preventing cardiac catheter thrombosis: an in vitro approach. | 2010 Apr |
1 |
| 3 |
17950793 | Effectiveness and safety of reduced-dose enoxaparin in non-ST-segment elevation acute coronary syndrome followed by antiplatelet therapy alone for percutaneous coronary intervention. | 2007 Nov 1 |
1 |
| 4 |
15957976 | Clinical use of enoxaparin in the management of non-ST segment elevation acute coronary syndromes. | 2005 Jun |
4 |
| 5 |
16052301 | Enoxaparin in clinical practice and clinical trials of non-ST-elevation Acute Coronary Syndrome (NSTE-ACS). | 2005 Apr |
3 |
| 6 |
16124952 | Exploring the role of enoxaparin in the management of high-risk patients with non-ST-elevation acute coronary syndromes: the SYNERGY trial. | 2005 Apr |
3 |
| 7 |
12784820 | Primary PCI for ST-segment elevation myocardial infarction in a patient treated with subcutaneous enoxaparin utilizing point-of-care Enox test. | 2003 May |
2 |
| 8 |
11096663 | Combination Enoxaparin and Abciximab During Percutaneous Coronary Intervention: A New Standard of Care? | 2000 May |
2 |